Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice (Q64127429)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice	article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

based on heuristic

inferred from title

author name string

Li Guo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jianwei Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Hongli Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Hongli Si

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Min Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jingdong Song

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Bingjuan Han

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Yi Shu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Lili Ren

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jianguo Qu

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Tao Hung

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

0 references

publication date

4 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

460-468

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Outbreaks of food-borne and waterborne viral gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Norwalk-like viral gastroenteritis outbreak in U.S. Army trainees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Molecular epidemiology of human enteric caliciviruses in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Molecular Epidemiology of “Norwalk‐like Viruses” in Outbreaks of Gastroenteritis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Detection of norwalk-like virus in shellfish implicated in illness.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Surveillance of small round structured virus (SRSV) infection in England and Wales, 1990-5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Detection of Norwalk virus or Norwalk-like virus infections in Finnish infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Molecular epidemiology of outbreaks of gastroenteritis associated with small round structured viruses in Germany in 1997/98.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Surveillance of viral gastroenteritis in Japan: pediatric cases and outbreak incidents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Norwalk virus infection in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Genomic diversity of "Norwalk like viruses" (NLVs): pediatric infections in a Brazilian shantytown

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Norwalk virus vaccines: challenges and progress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Norwalk virus genome cloning and characterization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Sequence and genomic organization of Norwalk virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Prevalence and genetic characterization of caliciviruses among children hospitalized for acute gastroenteritis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Norovirus capsid protein expressed in yeast forms virus-like particles and stimulates systemic and mucosal immunity in mice following an oral administration of raw yeast extracts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

A simple and efficient method for purification of infectious recombinant adenovirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Human caliciviruses in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Prospects for vaccine protection against HIV-1 infection and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Adenoviruses as vaccine vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

A recombinant human adenovirus expressing the simian immunodeficiency virus Gag antigen can induce long-lived immune responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Mucosal immunity: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Cellular and humoral immunity following Snow Mountain virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

High efficiency cross-reactive monoclonal antibody production by oral immunization with recombinant norwalk virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.039

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.11.039

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18160189%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64127429&oldid=1955722621"